WallStSmart
APM

Aptorum Group Ltd Class A

NASDAQ: APM · HEALTHCARE · BIOTECHNOLOGY

$0.83
-7.34% today

Updated 2026-06-05

Market cap
$8.71M
P/E ratio
P/S ratio
23.35x
EPS (TTM)
$-0.19
Dividend yield
52W range
$1 – $4
Volume
0.1M

Aptorum Group Ltd Class A (APM) Financial statements

SEC filings — annual and quarterly data.

Profit margin
0.00%
Operating margin
0.00%
ROE
-16.91%
ROA
-6.52%
Debt/equity
0.15x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2016$0.00$-2.13M
2017$0.00$-2.55M
2018$383450.00$-14.83M17.07%-2,693.44%-3,868.04%
2019$535166.00$-18.69M-48.40%-3,400.44%-3,491.81%
2020$911509.00$7.07M-11.41%-2,182.63%775.31%
2021$1.54M$-25.05M5.31%-1,245.59%-1,624.38%
2022$1.30M$-9.80M6.18%-1,351.01%-756.17%
2023$431378.00$-2.83M2.45%-2,457.47%-654.88%
2024$0.00$-4.27M
2025$0.00$-1.36M

Frequently asked questions

How much free cash flow does APM generate?

APM produced $-1.84M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is APM's balance sheet healthy?

APM holds $3.45M in cash and equivalents against — in long-term debt, on $23.12M of shareholder equity. That debt is best read against the cash flow the business throws off each year.